Sarah Diepstraten 34th Lorne Cancer Conference 2022

Abstracts this author is presenting:

• Whole genome CRISPR/Cas9 screening to understand resistance to BH3-mimetic drugs in lymphoma — Welcome Function and Poster Session 1